Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases

This publication has 61 references indexed in Scilit:

• Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
  Cell, 2012
• Activation of the HIF Prolyl Hydroxylase by the Iron Chaperones PCBP1 and PCBP2
  Cell Metabolism, 2011
• Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia
  PLOS ONE, 2010
• Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
  EMBO Molecular Medicine, 2010
• Antioxidants, HIF Prolyl Hydroxylase Inhibitors or Short Interfering RNAs to BNIP3 or PUMA, Can Prevent Prodeath Effects of the Transcriptional Activator, HIF-1α, in a Mouse Hippocampal Neuronal Line
  Antioxidants & Redox Signaling, 2008
• Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits
  Brain Research, 2008
• ATF4 is an oxidative stress–inducible, prodeath transcription factor in neurons in vitro and in vivo
  Journal of Experimental Medicine, 2008
• Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
  Molecular Cell, 2008
• The von Hippel-Lindau Tumor Suppressor Protein and Egl-9-Type Proline Hydroxylases Regulate the Large Subunit of RNA Polymerase II in Response to Oxidative Stress
  Molecular and Cellular Biology, 2008
• RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
  Nature, 2007